Conference Date and Location: December 6 & 7, 2018 at the InterContinental Hotel, Toronto
Ontario’s HIV sector is working to improve the health and well-being of people with and at risk of HIV – focusing on the prevention, engagement and care cascade. Where are the breakthrough opportunities to do better in clinical and community settings? How can the system work better to link people with or at risk of HIV to the care they need and help them stay engaged in care? What can providers do to improve quality to care and make HIV and related programs and services accessible to all?
HIV Endgame 3 will combine structured CME-credit plenary and educational sessions, with discussions of innovations in care and support. The program will focus on evidence-based interventions and approaches to care that build on Ontario’s strengths. It will highlight unique partnerships between clinicians and community-based service providers and between HIV and other sectors (e.g. housing, mental health, addictions). It will also explore how clinical care is evolving to meet targets and help achieve the vision of the HIV/AIDS Strategy to 2026 for Ontario.
We encourage clear plain-language communication that facilitates the application of the work you present. We invite researchers and care providers to submit abstracts and cases in one of these ten topic areas:
- Biomedical prevention/Combination prevention – Increasing PrEP uptake in various contexts as well as practical challenges for specific at-risk populations, and emerging biomedical prevention options; combination approaches to prevention.
- From cure to care – Are there early breakthroughs in cure research? Can they be used to improve care now?
- Testing and timely linkage to care – HIV/STI testing methods, such as supervised/unsupervised self-testing or dried-blood spot testing; strategies for uptake; strategies to link both newly diagnosed and high-risk people to care and to reach the undiagnosed; the role of navigators.
- Retention in care – Practical initiatives to foster life-long engagement in care for virally-suppressed patients and for those that may never be able to reach this target. The implications of U=U for patients and providers, how U=U can shape retention messages, and the implications/messages for groups (breastfeeding mothers, people who use drugs), who may feel excluded by the focus on U=U.
- Patient-centred and population-specific approaches to clinical care – Approaches to clinical care that integrate an understanding of the social determinants of health and/or the unique experiences of specific at-risk communities and populations, including pediatric patients transitioning to adult care.
- Providing care in under-served regions – What innovations are emerging in rural/remote areas and smaller cities to improve HIV care? How can urban clinic innovations can be adapted to serve clients in smaller centres?
- Medication changes – Emerging therapy options, new combinations and deprescribing, as well as the increasing challenges of drug interactions in HIV patients with multi-morbidities and chronic pain challenges.
- Mental health, addictions and trauma-informed care – Models and partnerships that integrate mental health and addictions support into clinical care; trauma-aware care that recognizes the violence and displacement many patients have experienced.
- Co-morbidities and aging – Co-morbidities often associated with aging (heart disease, diabetes, cancer); clinical supports for aging patients including long-term care and end of life care.
- New Technology – what can it offer? – What new features are being integrated into electronic medical records systems, made available as patient apps and other mobile technologies to improve patient outcomes and clinic operations?
- Training the Next Generation – Initiatives to provide the next generation with the skills needed for life-long multidisciplinary care.
Abstract Submission Instructions
Abstracts will be submitted electronically through the conference registration website. Use this link to submit your abstract. Abstracts should be in French or English and will be published in the language of submission. The abstract should not exceed 300 words.
The deadline to submit an abstract for HIV Endgame 3: Breakthrough Initiatives is August 3, 2018. The results of the peer review process will be communicated by email to the submitting author the week of October 15, 2018.